Frailty before chronic disease: multisystem physiological differences in middle-aged adults from the UK Biobank

Area of Science:

• Gerontology and Public Health
• Physiological markers of aging
• Disease prevention strategies

Background:

• Frailty, a state of vulnerability, primarily affects older adults but also occurs in younger, disease-free individuals.
• Understanding frailty in middle-aged, healthy populations offers insights into early physiological dysregulation.
• Identifying physiological markers associated with frailty can inform preventative strategies.

Purpose of the Study:

• To assess frailty status in a large cohort of disease-free middle-aged adults.
• To examine the associations between various physiological markers and frailty in this population.
• To understand the early physiological underpinnings of frailty preceding chronic disease.

Main Methods:

• Analysis of data from 117,163 disease-free middle-aged adults from the UK Biobank.
• Frailty was defined using the Fried Frailty Phenotype (robust, prefrail, frail).
• Multinomial logistic regression was used to associate 29 physiological markers with frailty status, adjusting for confounders.

Main Results:

• 1.1% were frail and 32.8% were prefrail.
• Frailty was associated with altered anthropometry, lipids, hepatic and renal function, glucose metabolism (HbA1c), inflammation (hsCRP), and white blood cell counts.
• Conversely, blood pressure, lung function (FEV1, FVC), certain hepatic/renal markers, and IGF-1 were inversely associated with frailty.

Conclusions:

• Frailty in disease-free middle-aged adults is characterized by multisystem physiological alterations.
• These changes mirror those seen in older, multimorbid populations, indicating early dysregulation.
• Findings suggest potential for early detection and intervention to mitigate frailty progression.